ERBB2 and breast carcinoma: In this study, eight of eleven triple-negative breast cancer cell lines were highly sensitive to TRAIL-induced apoptosis while cell lines representing hormone receptor positive or HER2 amplified breast cancer were either resistant or only moderately sensitive.